DUBLIN--(BUSINESS WIRE)--The "Interbody Fusion Cage Market by Product Type, Surgery, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
The global interbody fusion cages market was valued at $ 1,901.67 million in 2020, and is projected to reach $ 3,012.47 million by 2030, registering a CAGR of 4.7% from 2021 to 2030.
Interbody fusion cage is an artificial medical device, which is utilized in spinal fusion procedures to maintain foraminal height and decompression. The interbody fusion cage is a large, hollow cylinder made up of metals such as titanium, carbon fiber, or allograft femur. The device is designed as a cage so that bone graft can be placed inside the hollow cylinder to allow a spinal fusion to occur between two vertebrae. Interbody fusion cage utilized to provide stability to the spine and the cervical region. The cages can be filled with autologous bone material to promote arthrodesis (artificial induction of joint ossification).
The key factors that drive the market growth are rise in geriatric population and increase in spinal cord injuries, which might be caused due to accidents and diseases such as degenerative disk disease. However, high cost associated with spinal fusion surgeries and dearth of skilled professionals are anticipated to impede the growth of interbody fusion cage market. On the contrary, increased adoption of minimally invasive surgeries is projected to create ample opportunities in the market.
The interbody fusion cages market is segmented into product type, surgery, end user, and region. By product type, the market is segregated into lumbar cage, cervical cage, thoraco-lumbar cage, and thoracic cage. On the basis of surgery, it is fragmented into anterior, posterior, lateral, and transforaminal. Depending on end user, it is fragmented into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include Aurora Spine, Inc, B. Braun Melsungen AG, Benvenue Medical Inc., Prodorth, Ulrich Medicals, Orthofix, Medtronic Plc., Zimmer Biomet Holdings, Inc., NuVasive, Inc., and Johnson & Johnson.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global interbody fusion cage market with current trends and future estimations to elucidate the imminent investment pockets
- Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities
- Extensive analysis of the key segments of the industry helps to understand the products and technologies used globally
- Key market players and their strategies are provided to understand the competitive outlook of the market
By Product Type
- Lumbar Cage
- Cervical Cage
- Thoraco-lumbar Cage
- Thoracic Cage
By Surgery
- Anterior
- Posterior
- Lateral
- Transforaminal
By End User
- Hospital & Clinics
- Others
- Ambulatory Surgical Center
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY PLAYERS
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Boehringer Ingelheim
- GNI Group Ltd
- F. Hoffmann-La Roche Ltd (Genentech, Inc,)
- Shiongi co Ltd
- Mission Therapeutics
- Biogen, Inc
- Galapagos NV
- FibroGen, Inc
Key Topics Covered:
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Landscape
Chapter 4: Interbody Fusion Cages Market, by Product
Chapter 5: Interbody Fusion Cages Market, by Surgery
Chapter 6: Interbody Fusion Cages Market, by End-user
Chapter 7: Interbody Fusion Cages Market, by Region
Chapter 8: Company Profiles
Companies Mentioned
- Aurora Spine, Inc.
- B. Braun Melsungen AG
- Benvenue Medical Inc.
- Prodorth
- Ulrich Medicals
- Orthofix
- Medtronic Plc
- Zimmer Biomet Holdings, Inc.
- NuVasive, Inc.
- Johnson & Johnson.
For more information about this report visit https://www.researchandmarkets.com/r/mioo2m
